You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Tazemetostat for treating relapsed or refractory follicular lymphoma after 2 or more treatments [ID6349]
Discontinued
Reference number:
GID-TA11399
Project information
Project documents
Documents
Documents created during the development process.
Notes
Note
Back to top